Eddy Elfenbein submits: Bristol-Myers Squibb (BMY) has popped up on my radar screen as a decent value. The company had a lousy third-quarter earnings report, but the one for the fourth-quarter was pretty good. I was also impressed by the company's forward guidance. Here’s a look at the stock (in blue, left scale), earnings-per-share (gold, right scale) and dividend (black, right scale). The graph is scaled at a ratio of 16-to-1 so when the blue and gold lines cross, the P/E Ratio is 16; when the blue and black lines cross, the dividend yield is 6.66%. Complete Story »
Bristol-Myers Squibb: Looks Like a Good Value
Videos
Jack Crooks' World Currency Watch
